<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The results of T- and B-cell determinations are described in 105 cases of lymphoreticular and lymphoepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, and are compared to similar investigations of 582 cases as published in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, T- and B-cell values are determined in blood of 35 healthy individuals, in 12 <z:mpath ids='MPATH_458'>normal</z:mpath> lymph nodes, as well as in hyperplastic conditions of lymph nodes from 30 patients and of tonsils from 85 patients </plain></SENT>
<SENT sid="2" pm="."><plain>Cell characterizations are done by immunofluorescence and use of monospecific anti-immunoglobulin antisera (H chain specific), anti-thymus antiserum, as well as by the E-rosette test </plain></SENT>
<SENT sid="3" pm="."><plain>While <z:mpath ids='MPATH_458'>normal</z:mpath> blood and <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:mpath ids='MPATH_602'>hyperplastic tissues</z:mpath> show a polyclonal distribution or proliferation of lymphoreticular cells, neoplastic conditions are often characterized by an exuberant, possibly monoclonal proliferation of one cell type </plain></SENT>
<SENT sid="4" pm="."><plain>According to this, lymphoreticular <z:hpo ids='HP_0002664'>neoplasias</z:hpo> are immunologically grouped into four main classes: B-cell <z:hpo ids='HP_0002664'>neoplasias</z:hpo> comprising most of the <z:hpo ids='HP_0005550'>chronic lymphocytic leukemias</z:hpo>, well differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, BURKITT's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> BRILL-SYMMERS, and hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> represent a large part of poorly or undifferentiated <z:hpo ids='HP_0001909'>leukemias</z:hpo> of children, poorly differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, prolymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:e sem="disease" ids="C0036920" disease_type="Neoplastic Process" abbrv="">SÃ©zary's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Monocytic <z:hpo ids='HP_0002664'>neoplasias</z:hpo> are <z:e sem="disease" ids="C0019623" disease_type="Neoplastic Process" abbrv="">malignant histiocytoses</z:e> and <z:e sem="disease" ids="C0023443" disease_type="Neoplastic Process" abbrv="">leukemic reticuloendothelioses</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>A fourth group, which probably is not homogeneous and might be further classified in the future by use of more sophisticated methods, consists of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with T- and B-cell lack </plain></SENT>
<SENT sid="8" pm="."><plain>Such <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are histologically classified as Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, a certain number of histiocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The prognostic and pathogenetic implications of a combined morphological and immunological classification of lymphoreticular <z:hpo ids='HP_0002664'>neoplasias</z:hpo> are briefly outlined </plain></SENT>
</text></document>